The Food and Drug Administration (FDA) has also published a new data integrity guidance aimed at assisting pharmaceutical manufacturers to meet the regulator's standards; which relates to the agenda of Good Manufacturing Practice (GMP)-related concerns.
Various pharmaceutical industries who are in need for the right equipment and services are the company's main patrons. Esco Pharma visited various countries and participated in numerous exhibitions and conferences; staying true to its commitment of providing product awareness among healthcare professionals.
A filling line is an integral part of manufacturing sterile pharmaceutical products. It ensures that parenteral medications are prepared inside an ISO classified environment for the whole manufacturing cycle, which is achieved through the use of a Restricted Access Barrier System (RABS) or an isolator.
With the successful commencement of the first ever Philippine Herbal Medicine Summit last October 25, 2016, the University of the Philippines - National Institute of Health (UP - NIH) Institute of Herbal Medicine brings it back this October 4 - 5.
A novel drug delivery system has recently been acknowledged, and it is with the use of microspheres. They are defined as solid, spherical particles ranging in size from 1 to 1000 µm.
Last June 2017, the United States Food and Drug Administration (FDA) have released Draft Guidance regarding Product Identifier Requirements under the Drug Supply Chain Security Act (DSCSA).
Biosafety is defined as the discipline which addresses the containment and safe handling of infectious microorganisms and hazardous biological materials.
The International Society for Pharmaceutical Engineering (ISPE) released the term 'Advanced Aseptic Processing (AAP)', which covers both the Restricted Access Barrier System (RABS) and the isolators, which aims to cater for product protection and containment during on-going manufacturing operations by separating operators from the process.